OREX

Orexigen Therapeutics, Inc. News Headlines

$5.66
*  
0.11
1.91%
Get OREX Alerts
*Delayed - data as of Aug. 21, 2014 15:07 ET  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OREX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Sector Update: Healthcare
12/3/2013 9:24:34 AM - MT Newswires

Sector Update: Healthcare Shares Flat Pre-Market; Orexigen Sinks 5% on Private Offering
12/2/2013 8:56:49 AM - MT Newswires

Sector Update: Healthcare
12/2/2013 8:55:50 AM - MT Newswires

OREX' Positive Contrave Data Boosts Shares - Analyst Blog
11/26/2013 6:06:41 PM - Zacks.com

Orexigen Therapeutics (OREX) Jumps: Stock Rises 9.3% - Tale of the Tape
11/26/2013 10:39:01 AM - Zacks.com

Mid-Afternoon Market Update: Markets Turn Back as Momentum Stocks Drop
11/25/2013 4:48:58 PM - Benzinga

Mid-Day Market Update: SeaDrill Drops On Downbeat Earnings; Giant Interactive Shares Spike Higher
11/25/2013 2:04:49 PM - Benzinga

Mid-Morning Market Update: Markets Edge Higher; Wal-Mart Names New CEO
11/25/2013 11:36:57 AM - Benzinga

Pre-Market Most Active for Nov 25, 2013 : SIRI, OREX, ARIA, NOK, CAMT, BAC, INTC, EMC, SLM, VMW, CIM, HPT
11/25/2013 9:39:56 AM - NASDAQ.com News

Narrower Loss at Orexigen in Q3 - Analyst Blog
11/14/2013 10:06:40 AM - Zacks.com

Orexigen, Sanofi Ink Deal - Analyst Blog
11/7/2013 6:05:26 PM - Zacks.com

Moving Average Crossover: Great News for Orexigen Therapeutics, Inc. (OREX) ? - Tale of the Tape
11/7/2013 9:55:01 AM - Zacks.com

Arena to Double Belviq Sales Force - Analyst Blog
10/16/2013 12:46:35 PM - Zacks.com

Update on Orexigen's Contrave - Analyst Blog
10/8/2013 11:44:45 AM - Zacks.com

Cramer's Lightning Round - You Will See Profit Taking In Netflix (10/7/13)
10/8/2013 6:10:00 AM - Seeking Alpha

Orexigen Seeks Approval In Europe For Anti-Obesity Pill
10/3/2013 11:05:00 PM - Seeking Alpha

VIVUS' Hopes Tied to Qsymia - Analyst Blog
9/25/2013 11:17:42 AM - Zacks.com

Novo Nordisk Advertising Weight Loss - A Future Peak At Arena Or Vivus?
9/24/2013 3:14:00 AM - Seeking Alpha

Vivus Will Try Again In Europe With Anti-Obesity Drug
9/20/2013 12:54:00 PM - Seeking Alpha

Update on Arena/Eisai's Belviq - Analyst Blog
9/18/2013 11:50:01 AM - Zacks.com

EnteroMedics: Arena 2.0?
9/12/2013 6:26:00 AM - Seeking Alpha

Strong Acquisition Target Solta Poised To Challenge In Fat Loss And Skin Care Markets
9/10/2013 7:50:00 AM - Seeking Alpha

Biotech Investor Realism With Andrew Fein
9/4/2013 1:36:00 PM - Seeking Alpha

More Shakeups At Vivus: CEO Resigns
9/3/2013 2:40:00 PM - Seeking Alpha

Pipeline at Arena Pharma Advances - Analyst Blog
8/30/2013 4:30:01 PM - Zacks.com